Cryptosporidium: Host-Parasite Interactions and Pathogenesis

[1]  C. Hunter,et al.  The intestinal parasite Cryptosporidium is controlled by an enterocyte intrinsic inflammasome that depends on NLRP6 , 2020, Proceedings of the National Academy of Sciences.

[2]  L. Sibley,et al.  Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells , 2020, mBio.

[3]  Adam Sateriale,et al.  Crypto-Currency: Investing in New Models to Advance the Study of Cryptosporidium Infection and Immunity , 2020, Frontiers in Cellular and Infection Microbiology.

[4]  S. Vinayak.  Recent advances in genetic manipulation of Cryptosporidium. , 2020, Current opinion in microbiology.

[5]  R. O’Connor,et al.  Cryptosporidium: host and parasite transcriptome in infection. , 2020, Current opinion in microbiology.

[6]  H. Ward,et al.  Intestinal organoid/enteroid-based models for Cryptosporidium , 2020, Current opinion in microbiology.

[7]  B. Striepen,et al.  The Biology of the Intestinal Intracellular Parasite Cryptosporidium. , 2020, Cell host & microbe.

[8]  S. Schreiber,et al.  Bicyclic azetidines kill the diarrheal pathogen Cryptosporidium in mice by inhibiting parasite phenylalanyl-tRNA synthetase , 2020, Science Translational Medicine.

[9]  S. Vinayak,et al.  A Conditional Protein Degradation System To Study Essential Gene Function in Cryptosporidium parvum , 2020, mBio.

[10]  J. Kissinger,et al.  Noncoding RNAs in Apicomplexan Parasites: An Update. , 2020, Trends in parasitology.

[11]  L. Sibley,et al.  Defining Stage-Specific Activity of Potent New Inhibitors of Cryptosporidium parvum Growth In Vitro , 2020, mBio.

[12]  M. Santín.  Cryptosporidium and Giardia in Ruminants. , 2020, The Veterinary clinics of North America. Food animal practice.

[13]  E. Innes,et al.  A One Health Approach to Tackle Cryptosporidiosis , 2020, Trends in Parasitology.

[14]  Deborah A Schaefer,et al.  Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics , 2019, Methods in molecular biology.

[15]  D. Kaplan,et al.  Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium. , 2019, Methods in molecular biology.

[16]  L. Hedstrom,et al.  Genetic ablation of purine salvage in Cryptosporidium parvum reveals nucleotide uptake from the host cell , 2019, Proceedings of the National Academy of Sciences.

[17]  Megan C. Sullivan,et al.  Life cycle progression and sexual development of the apicomplexan parasite Cryptosporidium parvum , 2019, Nature Microbiology.

[18]  L. Sibley,et al.  A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability , 2019, Cell host & microbe.

[19]  C. Hunter,et al.  A Genetically Tractable, Natural Mouse Model of Cryptosporidiosis Offers Insights into Host Protective Immunity , 2019, Cell host & microbe.

[20]  C. Huston,et al.  A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors , 2019, Nature Communications.

[21]  Tamer Farag,et al.  The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS) , 2019, The Lancet. Global health.

[22]  G. Martins,et al.  Induction of a Long Noncoding RNA Transcript, NR_045064, Promotes Defense Gene Transcription and Facilitates Intestinal Epithelial Cell Responses against Cryptosporidium Infection , 2018, The Journal of Immunology.

[23]  S. Tzipori,et al.  The piglet acute diarrhea model for evaluating efficacy of treatment and control of cryptosporidiosis , 2018, Human vaccines & immunotherapeutics.

[24]  G. Kang,et al.  Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study , 2018, The Lancet. Global health.

[25]  H. Clevers,et al.  Modeling Cryptosporidium infection in human small intestinal and lung organoids , 2018, Nature Microbiology.

[26]  L. Sibley,et al.  Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro , 2018, mSphere.

[27]  G. Kang,et al.  Epidemiology and Risk Factors for Cryptosporidiosis in Children From 8 Low-income Sites: Results From the MAL-ED Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Guang-Hui Zhao,et al.  Nuclear delivery of parasite Cdg2_FLc_0220 RNA transcript to epithelial cells during Cryptosporidium parvum infection modulates host gene transcription. , 2018, Veterinary parasitology.

[29]  N. Mabbott,et al.  Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies , 2017, Veterinary Research.

[30]  B. Striepen,et al.  Generating and Maintaining Transgenic Cryptosporidium parvum Parasites , 2017, Current protocols in microbiology.

[31]  Yinan Lin,et al.  Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum , 2017, Infection and Immunity.

[32]  Xian-Ming Chen,et al.  Delivery of Parasite RNA Transcripts Into Infected Epithelial Cells During Cryptosporidium Infection and Its Potential Impact on Host Gene Transcription , 2016, The Journal of infectious diseases.

[33]  N. Askari,et al.  Evaluation of recombinant P23 protein as a vaccine for passive immunization of newborn calves against Cryptosporidium parvum , 2016, Parasite immunology.

[34]  P. Karanis,et al.  The Ultra‐Structural Similarities between Cryptosporidium parvum and the Gregarines , 2016, The Journal of eukaryotic microbiology.

[35]  Mark A. Miller,et al.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.

[36]  Rebecca D. Oppenheim,et al.  Epicellular Apicomplexans: Parasites “On the Way In” , 2015, PLoS pathogens.

[37]  M. Cipriano,et al.  Genetic modification of the diarrheal pathogen Cryptosporidium parvum , 2015, Nature.

[38]  Mark A. Miller,et al.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium. , 2015, The Lancet. Infectious diseases.

[39]  J. Långmark,et al.  Large Outbreak of Cryptosporidium hominis Infection Transmitted through the Public Water Supply, Sweden , 2014, Emerging infectious diseases.

[40]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[41]  I. Coppens,et al.  Identification and Characterization of Cryptosporidium parvum Clec, a Novel C-Type Lectin Domain-Containing Mucin-Like Glycoprotein , 2013, Infection and Immunity.

[42]  P. Hunter,et al.  Cryptosporidium Pathogenicity and Virulence , 2013, Clinical Microbiology Reviews.

[43]  A. Daugschies,et al.  Therapy and prevention of cryptosporidiosis in animals. , 2012, Veterinary parasitology.

[44]  D. Nydam,et al.  Antibody responses following administration of a Cryptosporidium parvum rCP15/60 vaccine to pregnant cattle. , 2011, Veterinary parasitology.

[45]  S. D. Rider,et al.  Cryptosporidium: genomic and biochemical features. , 2010, Experimental parasitology.

[46]  Lihua Xiao.  Molecular epidemiology of cryptosporidiosis: an update. , 2010, Experimental parasitology.

[47]  B. Amadi,et al.  High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial , 2009, BMC infectious diseases.

[48]  G. Kang,et al.  Polymorphic Mucin Antigens CpMuc4 and CpMuc5 Are Integral to Cryptosporidium parvum Infection In Vitro , 2009, Eukaryotic Cell.

[49]  Paul A. Bosela,et al.  Cryptosporidium Outbreak (Water Treatment Failure): North Battleford, Saskatchewan, Spring 2001 , 2008 .

[50]  R. Fayer,et al.  A longitudinal study of cryptosporidiosis in dairy cattle from birth to 2 years of age. , 2008, Veterinary parasitology.

[51]  J. Šlapeta,et al.  Cryptosporidia: epicellular parasites embraced by the host cell membrane. , 2008, International journal for parasitology.

[52]  A. Cevallos,et al.  Cryptosporidium parvum glycoprotein gp40 localizes to the sporozoite surface by association with gp15. , 2007, Molecular and biochemical parasitology.

[53]  J. Barta,et al.  What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. , 2006, Trends in parasitology.

[54]  J. Wanyiri,et al.  Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. , 2006, Future microbiology.

[55]  Huw Smith,et al.  Cryptosporidium excystation and invasion: getting to the guts of the matter. , 2005, Trends in parasitology.

[56]  Gregory A. Buck,et al.  The genome of Cryptosporidium hominis , 2004, Nature.

[57]  N. LaRusso,et al.  Phosphatidylinositol 3-Kinase and Frabin Mediate Cryptosporidium parvum Cellular Invasion via Activation of Cdc42* , 2004, Journal of Biological Chemistry.

[58]  Ping Xu,et al.  Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum , 2004, Science.

[59]  Jessica C Kissinger,et al.  Gene transfer in the evolution of parasite nucleotide biosynthesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Keithly,et al.  Expression and functional characterization of a giant Type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum. , 2004, Molecular and biochemical parasitology.

[61]  N. LaRusso,et al.  Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. , 2003, Gastroenterology.

[62]  B. Amadi,et al.  Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial , 2002, The Lancet.

[63]  S. Tzipori,et al.  Molecular Cloning and Expression of a Gene EncodingCryptosporidium parvum Glycoproteins gp40 and gp15 , 2000, Infection and Immunity.

[64]  D. Clark,et al.  Cryptosporidium parvum Induces Host Cell Actin Accumulation at the Host-Parasite Interface , 2000, Infection and Immunity.

[65]  M. Riggs,et al.  Cryptosporidium parvum Apical Complex Glycoprotein CSL Contains a Sporozoite Ligand for Intestinal Epithelial Cells , 1999, Infection and Immunity.

[66]  M. Jones,et al.  Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein. , 1999, Vaccine.

[67]  C. Speer,et al.  A Role for Host Phosphoinositide 3-Kinase and Cytoskeletal Remodeling during Cryptosporidium parvumInfection , 1999, Infection and Immunity.

[68]  J. Gut,et al.  A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. , 1998, Molecular and biochemical parasitology.

[69]  A. Crisanti,et al.  Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. , 1998, Molecular and biochemical parasitology.

[70]  A. Stone,et al.  Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. , 1997, Journal of immunology.

[71]  D. Jasmer,et al.  A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. , 1996, Molecular and biochemical parasitology.

[72]  J. P. Davis,et al.  A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. , 1994, The New England journal of medicine.

[73]  R. Fayer,et al.  General biology of Cryptosporidium. , 1990 .

[74]  N. C. Reese,et al.  A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. , 1986, The Journal of protozoology.